Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 43 (RPL31P43)

Target
RPL31P43
Molecular classification
Other (Pseudogene)
01

Overview

RPL31P43 (Ribosomal protein L31 pseudogene 43) is a processed pseudogene derived from the ribosomal protein L31 gene. Pseudogenes are segments of DNA similar to normal genes but typically non-functional due to mutations that prevent them from coding for proteins. RPL31P43 has sequence homology to the functional *RPL31* gene, which encodes a component of the 60S ribosomal subunit and is essential for protein synthesis in cells. Unlike the active ribosomal protein L31, RPL31P43 is not transcribed into a functional protein and does not serve known biological or therapeutic roles. It may exist as an expressed non-coding RNA, but no studies have characterized specific regulatory or disease-related functions of RPL31P43. It is catalogued among many processed pseudogenes in the human genome, particularly for ribosomal proteins, but is not a validated drug target, biomarker, or therapeutic receptor. If you are seeking information on the functional ribosomal protein, refer to *RPL31* instead of its pseudogene variants.

Other names
RPL31_21_1004RPL31P43
02

Mechanism of action

None applicable

03

Biological functions

None directly
04

Disease associations

None established
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None known

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 43 (RPL31P43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 43 (RPL31P43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call